VIM enzymes hydrolyze carbapenems and most other beta-lactams. VIM-producing organisms — particularly Pseudomonas aeruginosa and certain Enterobacterales — are responsible for serious, difficult-to-treat hospital infections.
Detection of blaVIM in molecular testing guides use of specialized antibiotic combinations and supports infection control. Sample type is typically a culture isolate or direct specimen.